CVT 2501
Latest Information Update: 16 Jul 2002
At a glance
- Originator CV Therapeutics
- Class
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 13 Sep 2000 New profile
- 13 Sep 2000 Preclinical development for Arrhythmias in USA (Unknown route)